GLP-3
GLP-1/GIP/Glucagon Triple Agonist
Single vials
| Size | Per vial | Per mg |
|---|---|---|
| 10 mg | $180.00 | $18.00 |
| 15 mg | $210.00 | $14.00 |
| 20 mg | $290.00 | $14.50 |
| 30 mg | $370.00 | $12.33 |
Every listing is a single vial. The per-mg figure is shown for comparison only.
98% minimum purity, verified by HPLC.
For in vitro research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.
Request Certificate of AnalysisIssued per batch. Allow 1–2 business days.
Lyophilised powder in a single sealed vial. 98% minimum purity, verified by HPLC. For in vitro research and laboratory use only.
About this compound
GLP-3 is a synthetic peptide acting as a triple agonist at the GLP-1, GIP and glucagon receptors. It represents a novel research compound in the incretin mimetic class currently under laboratory investigation.
GLP-3 supplied as lyophilised powder in a single sealed vial. Available in 10 mg, 15 mg, 20 mg, 30 mg.
Every batch is assayed by an accredited third-party laboratory to a 98% minimum purity standard, verified by HPLC. Certificates of Analysis are issued per batch and supplied on request — use the Request Certificate of Analysis link on this page and quote your order number.
Supplied to registered research counterparties only. For in vitro research and laboratory use only. Not for human consumption. Not intended to diagnose, treat, cure or prevent any disease.
Quick facts
- Class
- GLP-1/GIP/Glucagon Triple Agonist
- Format
- Lyophilised powder
- Sizes
- 10 mg, 15 mg, 20 mg, 30 mg
- Supplied as
- Single vial
- Purity
- 98% minimum, HPLC verified
- Category
- Metabolic
- Use
- Research use only
Research
- Retatrutide-A Game Changer in Obesity Pharmacotherapy
- Triple-Hormone-Receptor Agonist Retatrutide for Obesity – A Phase 2 Trial
- Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Peer-reviewed literature referencing this compound, listed for reference. Aletheia Wellness is not affiliated with these publications and makes no claim based on them.





